COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey

Affiliations

• ¹ Immunoallergology Unit, Careggi University Hospital, Florence, Italy.
• ² Department of Medicine, Allergy Unit and Asthma Center, University of Verona and Verona University Hospital, Verona, Italy.
• ³ Respiratory Pathophysiology Unit, Department of Cardiological, Thoracic and Vascular Sciences, University of Padua, Italy.
• ⁴ Cardio-Thoracic Department, Respiratory Unit, Integrated University Hospital, Verona, Italy.
• ⁵ Department of Medical Specialties, Pneumology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia-IRCCS, Reggio Emilia, Italy.
• ⁶ Department of Medicine, Respiratory Medicine Unit and Section of Internal Medicine, University of Verona and Verona University Hospital, Verona, Italy.
• ⁷ Allergy and respiratory diseases, DIMI Department of Internal Medicine, University of Genoa, Ospedale Policlinico San Martino, Genoa, Italy.
• ⁸ Departmental Unit of Allergology, Istituto Ospedaliero "Fondazione Poliambulanza", Brescia, Italy.
• ⁹ Immunology and Cell Therapy Unit, Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.
• ¹⁰ Allergology Unit - Occupational Medicine, Department of Cardiological, Thoracic and Vascular Sciences, University of Padua, Padua, Italy.
• ¹¹ UOC Pneumologia Cittadella, Euganea, Italy.